BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10929874)

  • 1. High-level amikacin resistance in Pseudomonas aeruginosa associated with a 3'-phosphotransferase with high affinity for amikacin.
    Torres C; Perlin MH; Baquero F; Lerner DL; Lerner SA
    Int J Antimicrob Agents; 2000 Aug; 15(4):257-63. PubMed ID: 10929874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence and mechanisms of amikacin resistance and its association with beta-lactamases in Pseudomonas aeruginosa: a Korean nationwide study.
    Kim JY; Park YJ; Kwon HJ; Han K; Kang MW; Woo GJ
    J Antimicrob Chemother; 2008 Sep; 62(3):479-83. PubMed ID: 18606785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycoside phosphotransferase-II-mediated amikacin resistance in Escherichia coli.
    Bongaerts GP; Kaptijn GM
    Antimicrob Agents Chemother; 1981 Sep; 20(3):344-50. PubMed ID: 6272630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake.
    Perlin MH; Lerner SA
    Antimicrob Agents Chemother; 1986 Feb; 29(2):216-24. PubMed ID: 2424366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of
    Mohanam L; Menon T
    Indian J Med Microbiol; 2017; 35(2):282-285. PubMed ID: 28681822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
    Reyonolds AV; Hamilton-Miller JM; Brumfitt W
    J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin resistance associated with a plasmid-borne aminoglycoside phosphotransferase in Escherichia coli.
    Perlin MH; Lerner SA
    Antimicrob Agents Chemother; 1979 Nov; 16(5):598-604. PubMed ID: 393165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa.
    Islam S; Jalal S; Wretlind B
    Clin Microbiol Infect; 2004 Oct; 10(10):877-83. PubMed ID: 15373880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus.
    Fujimura S; Tokue Y; Takahashi H; Kobayashi T; Gomi K; Abe T; Nukiwa T; Watanabe A
    FEMS Microbiol Lett; 2000 Sep; 190(2):299-303. PubMed ID: 11034295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa serotype O11 isolates.
    Kettner M; Milosovic P; Hletková M; Kallová J
    Infection; 1995; 23(6):380-3. PubMed ID: 8655211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of amikacin resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Hurley JC; Miller GH; Smith AL
    Diagn Microbiol Infect Dis; 1995 Aug; 22(4):331-6. PubMed ID: 8582138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
    Stratton CW; Weeks LS; Tausk F
    J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods].
    Jakoniuk P; Wieczorek P; Sacha PT; Zalewska M; Leszczyńska K
    Med Dosw Mikrobiol; 2006; 58(4):363-70. PubMed ID: 17642314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMINOGLYCOSIDE RESISTANCE GENES IN Pseudomonas aeruginosa ISOLATES FROM CUMANA, VENEZUELA.
    Teixeira B; Rodulfo H; Carreño N; Guzmán M; Salazar E; De Donato M
    Rev Inst Med Trop Sao Paulo; 2016; 58():13. PubMed ID: 27007556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
    Zarrilli R; Tripodi MF; Di Popolo A; Fortunato R; Bagattini M; Crispino M; Florio A; Triassi M; Utili R
    J Antimicrob Chemother; 2005 Nov; 56(5):827-35. PubMed ID: 16186168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S; Vera D; Ramírez-Ronda CH
    Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects.
    Xiong YQ; Caillon J; Drugeon H; Potel G; Baron D
    Antimicrob Agents Chemother; 1996 Jan; 40(1):35-9. PubMed ID: 8787875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation on the use of beta-lactamase and aminoglycoside modifying enzyme gene sequences as markers for the early detection of antibiotic resistance profile of Pseudomonas aeruginosa.
    Doss VA; Parvathi S; Raju BA; Devi NA
    Dis Markers; 2004; 20(6):317-23. PubMed ID: 15665392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa.
    Yokoyama K; Doi Y; Yamane K; Kurokawa H; Shibata N; Shibayama K; Yagi T; Kato H; Arakawa Y
    Lancet; 2003 Dec; 362(9399):1888-93. PubMed ID: 14667745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.